Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL27577835 | 1.00 | CA4 (0.50) | — | |
| Glycine SCHEMBL27196 | 0.96 | — | — | |
| Glycine SCHEMBL2184513 | 0.96 | CA4 (0.53) | — | |
| Glycine SCHEMBL10725312 | 0.96 | CA4 (0.53) | — | |
| Glycine SCHEMBL3216076 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL20239631 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL20239641 | 0.92 | — | — | |
| Glycine SCHEMBL20239648 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL1483142 | 0.92 | CA4 (0.44) | — | |
| Glycine SCHEMBL15842973 | 0.92 | CA4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119082815-A | Platinum electroplating solution, preparation method thereof and application thereof in wafer electroplating | 昆山一鼎工业科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118668195-B | Electroless platinating solution, preparation method thereof and application thereof in wafer electroless platinating | 昆山一鼎工业科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118668195-A | Electroless platinating solution, preparation method thereof and application thereof in wafer electroless platinating | 昆山一鼎工业科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-4206645-B1 | METHOD AND APPARATUS FOR REMOVING OR REDUCING FORMATION OF PRECIPITATES GENERATED IN HEMATOXYLIN SOLUTIONS | VENTANA MED SYST INC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250213645-A1 | PHARMACEUTICAL COMPOSITION FOR MODULATING IMMUNE RESPONSE | L-Base Co., Ltd. (KR) | 2025-07-03 | — | — | US | disclosed |
| CN-119082815-A | Platinum electroplating solution, preparation method thereof and application thereof in wafer electroplating | 昆山一鼎工业科技有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-118668195-B | Electroless platinating solution, preparation method thereof and application thereof in wafer electroless platinating | 昆山一鼎工业科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118668195-A | Electroless platinating solution, preparation method thereof and application thereof in wafer electroless platinating | 昆山一鼎工业科技有限公司 | 2024-09-20 | — | — | CN | disclosed |
| US-20240207355-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG | L-Base Co., Ltd. (KR) | 2024-06-27 | — | — | US | disclosed |
| EP-4062974-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | L BASE CO LTD (KR) | 2024-05-08 | — | — | EP | disclosed |
| EP-4335452-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG | L-Base Co., Ltd. (KR) | 2024-03-13 | — | — | EP | disclosed |
| CN-1816390-A | Sol containing titanium dioxide, thin film formed therefrom and production process of the sol | SHOWA DENKO KK (JP) | 2006-08-09 | — | — | CN | disclosed |
| US-20060160754-A1 | Glycyrrhizin high-concentration preparation | NIPPON ZOKI PHARMACEUTICAL CO. LTD. (JP) | 2006-07-20 | — | — | US | disclosed |
| EP-1676580-A1 | GLYCYRRHIZIN HIGH-CONCENTRATION PREPARATION | Nippon Zoki Pharmaceutical Co. Ltd. (JP) | 2006-07-05 | — | — | EP | disclosed |
| EP-1644115-A2 | SOL CONTAINING TITANIUM DIOXIDE, THIN FILM FORMED THEREFROM AND PRODUCTION PROCESS OF THE SOL | Showa Denko K.K. (JP) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005003035-A2 | SOL CONTAINING TITANIUM DIOXIDE, THIN FILM FORMED THEREFROM AND PRODUCTION PROCESS OF THE SOL | SHOWA DENKO K.K. (JP) | 2005-01-13 | — | — | WO | disclosed |
| EP-0876385-B1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | OPUS DIAGNOSTICS INC (US) | 2000-10-18 | — | — | EP | disclosed |
| US-5952187-A | ANTIEPILEPTIC AGENT ANALOG DERIVATIZED AT THE SULFAMATE MOIETY OR THE 9-CARBON METHYL GROUP TO ADD LABEL FOR USE IN IMMUNOASSAYS OR TO ADD CARRIER FOR USE AS IMMUNOGEN; FOR MONITORING SERUM OR PLASMA LEVELS OF DRUG | OXIS INTERNATIONAL, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0876385-A1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | Oxis International, Inc. (US) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997019950-A1 | TOPIRAMATE IMMUNOASSAY, AS WELL AS ANALOGS AND ANTIBODIES | OXIS INTERNATIONAL, INC. (US) | 1997-06-05 | — | — | WO | disclosed |